Pharmaceutical And Biotech Expansion Will Fuel Future Success

Shared on07 May 25
Fair value Decreased 4.53%

Shared on30 Apr 25
Fair value Decreased 7.66%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 1.23%

AnalystConsensusTarget has increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on16 Apr 25
Fair value Increased 15%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.73%

Shared on02 Apr 25
Fair value Decreased 16%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 2.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.